| Fidelia Nabi Nitah, APRN, FNP-BC | |
|
1 S Bryant Ave, Edmond, OK 73034-6309 | |
| (405) 359-5370 | |
| (405) 359-5481 |
| Full Name | Fidelia Nabi Nitah |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1 S Bryant Ave, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134713373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 200703 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fidelia Nabi Nitah, APRN, FNP-BC 1 S Bryant Ave, Edmond, OK 73034-6309 Ph: (405) 359-5370 | Fidelia Nabi Nitah, APRN, FNP-BC 1 S Bryant Ave, Edmond, OK 73034-6309 Ph: (405) 359-5370 |
News Archive
Dr. Lena Al-Harthi speaks to News-Medical about her research into HIV treatment and the role of brain cells in spreading the HIV virus.
CANCER RESEARCH UK scientists have developed a new imaging technique that uses vitamin C to detect cancers likely to be more aggressive or resistant to treatment, according to a study published in the Journal of the American Chemical Society today.
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging describes a new class of radiopharmaceuticals, named radiohybrids, that offer a fresh perspective on cancer imaging and radioligand therapy.
According to the World Health Organization (WHO), 150,000 children with HIV under 15 years of age died of opportunistic infections in low-to-middle income countries in 2014 alone.
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
› Verified 7 days ago
Michelle Kathleen Merrell, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3800 S. Blvd,, Edmond, OK 73013 Phone: 405-905-9888 | |
Catherine Marie Kindt, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2177 Venezia Cir, Edmond, OK 73034 Phone: 580-695-1605 | |
Karyl S. Knopps, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2820 N Kelly Ave, Ste 200, Edmond, OK 73003 Phone: 405-726-8000 Fax: 405-726-8101 | |
Lisa Louise Spence, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1208 W 15th St, Edmond, OK 73013 Phone: 405-340-2100 Fax: 405-340-1184 | |
Elizabeth Stanfield Carradini, DNP, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1520 S Bryant Ave, Edmond, OK 73013 Phone: 405-348-7982 | |
Kelli Rebecca Lawrence, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 N Bryant Ave Ste 120, Edmond, OK 73034 Phone: 405-832-6881 Fax: 833-941-1685 | |
Dr. Magdalyn Boegler, DNP, APRN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7225 Skipping Stone Dr, Edmond, OK 73034 Phone: 405-887-3556 |